Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

67.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 89.50
  • 52 Week Low: 43.25
  • Currency: UK Pounds
  • Shares Issued: 471.33m
  • Volume: 461,691
  • Market Cap: £315.79m
  • RiskGrade: 461
  • Beta: 0.01

Avacta Group Overview

Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION™ platforms.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -26756.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2898.9 n/a
Pr/Book 132.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Avacta Group Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 2.94 (29.19) (10.57)p n/a n/a n/a n/a 0.0%
31-Dec-22 9.65 (41.64) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 2.85 (31.12) (10.69)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.11 (28.98) (8.54)p n/a n/a n/a n/a 0.0%
31-Dec-25 0.11 (36.84) (9.27)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Avacta Group Company Announcements

Accelerated Amortized Payment of Bond Installment 09-Jul-2026 07:00 RNS
Avacta Appoints Patrick Vink Deputy Chairman 08-Jul-2026 07:00 RNS
FDA Agreement on Pivotal Trial Design for AVA6000 25-Jun-2026 07:00 RNS

Avacta Group ShareCast News

Avacta Therapeutics appoints Patrick Vink as dep... 08-Jul-2026 ShareCast
Avacta agrees design of pivotal US cancer therap... 25-Jun-2026 ShareCast
Avacta flags strong progress across oncology pip... 22-Jun-2026 ShareCast

Latest Avacta Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 67.00p
Change Today -0.50p
% Change -0.74 %
52 Week High 89.50
52 Week Low 43.25
Volume 461,691
Shares Issued 471.33m
Market Cap £315.79m
Beta 0.01
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average
Price Trend
37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average
Income Not Available
Growth
40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average
58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average

Avacta Group Dividends

No dividends found

Trades for 07-Aug-2026

Time Volume / Share Price
16:26 1,505 @ 66.75p
16:26 1,473 @ 67.40p
16:22 14,998 @ 66.73p
16:20 5,000 @ 67.40p
16:16 174 @ 66.50p

Avacta Group Key Personnel

CEO Christina Coughlin
CFO Brian Hahn

Top of Page